Leaders from the R&D, Commercial, and Venture Communities Converge to Explore the Challenges of Moving New Technologies from R&D to Commercialization
MENLO PARK, Calif.--Sept. 15, 2004--On Tuesday, September 21, SRI International, in association with the IBDNetwork (http://www.ibdnetwork.com/), will host "Innovation Success: From R&D to Commercialization." Experts from both the R&D and commercial sectors will explore the challenges of moving technology from the research stage to commercialization. Attendees will get an exclusive look into how technology and product innovation is brought to market. The public and members of the media are invited to attend.
Who: SRI International and IBDNetwork
What: Strategy Series Seminar: "Innovation Success: From R&D to Commercialization"
When: September 21, 2004, 6:30-8:30 p.m.
Where: SRI International -- International Building
333 Ravenswood Ave.
Menlo Park, California
Introduction: Dr. Curtis Carlson, CEO, SRI International
Moderator: Tom Foremski, Silicon Valley Columnist, Financial Times
Speakers:
Innovation in Action
Kensington, whose "Idea Anywhere" approach to innovative product development has made it a leading supplier of consumer technology accessories, will display some of its award-winning products and offer them as attendee door prizes.
Following the introduction by SRI's Dr. Curt Carlson, panelists and attendees will explore the following topics:
To register to attend this event, please visit http://www.acteva.com/booking.cfm?bevaid=71104. Members of the media may register at no cost by contacting
Ellie Javadi at ellie.javadi@sri.com or 650-859-4874.
About SRI International
Silicon Valley-based SRI International (www.sri.com) is one of the world's leading independent research and technology development organizations. Founded as Stanford Research Institute in 1946, SRI has been meeting the strategic needs of clients for more than 55 years. The nonprofit research institute performs contract research and development for government agencies, commercial businesses and private foundations. In addition to conducting contract R&D, SRI licenses its technologies, forms strategic partnerships, and creates spin-off companies.









